https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.1084884/full
Frontiers | Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in...
AbstractObjective: To investigate the effect of Hsp27 and the inhibitory effect of Atractylenolide I (ATL-1) on the proliferation of prostate cancer cell DU1...
frontiersatractylenolideinhibitsemtenhances